Associations of Fc gamma receptor (FcgR2a, FcgR3a and FcgR2c) genotype with outcome in metastatic renal cell carcinoma (mRCC) patients receiving high dose interleukin 2 (HD-IL2)

ABSTRACT:

SUBMITTER: Erbe A 

PROVIDER: S-EPMC4649327 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature